Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'

Zinger Key Points
  • Steven Grasso of Grasso Global picks Applied Digital.
  • Julie Biel names West Pharmaceutical Services as her final trade.

On CNBC's “Halftime Report Final Trades,” Tim Seymour of Seymour Asset Management picked Cameco Corporation CCJ.

On Nov. 7, Cameco posted a loss for the third quarter but raised its FY24 revenue guidance.

Julie Biel of Kayne Anderson Rudnick named West Pharmaceutical Services, Inc. WST, saying this health care trade is “overblown.”

On Oct. 24, West Pharmaceutical Services reported adjusted EPS of $1.85, down from $2.16 a year ago, beating the consensus of $1.50. The designer and manufacturer of injectable pharmaceutical packaging and delivery systems reported sales of $746.9 million, beating the consensus of $709.62 million.

Don't forget to check out ou premarket coverage here

Karen Finerman of Metropolitan Capital Advisors said she likes iShares Biotechnology ETF IBB here.

Steven Grasso of Grasso Global Inc. named Applied Digital Corporation APLD as his final trade.

Nvidia's NVDA 13F fling, last week, showed it purchased 7.72 million Applied Digital shares worth $63.66 million as of Sept. 30, which translates into close to a 3.6% stake in Applied Digital, which had 215.36 million outstanding shares as of Oct. 8,

Price Action:

  • West Pharmaceutical shares dipped 7% to close at $314.49 on Friday.
  • Cameco shares gained by 0.9% to settle at $53.59 during Friday's session.
  • iShares Biotechnology ETF fell by 4.8% during Friday's session.
  • Applied Digital shares gained 5.4% to settle at $7.23.

Check This Out:

Image: Courtesy of Cameco

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasNewsTop StoriesMarketsMediaTrading IdeasCNBCHalftime Report Final TradesJulie BielKaren FinermanSteven GrassoTim Seymour
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!